av-101
Generic: imatinib
av-101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Jade Biosciences, Inc. (JBIO) | Preclinical |
Get deeper analysis on av-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis